颈外动脉栓塞用顺铂白蛋白微球的研究  

STUDY ON CISPLATIN ALBUMIN MICROSPHERES FOR NECK EXTERNAL ARTERY EMBOLIZATION

作　　者：程宇慧[1] 李栗[2] 傅风华[3] 刘艳云[1] 廖工铁[1] 侯世祥[1] 温玉明[3] 

机构地区：[1]华西医科大学药学院 [2]华西医科大学基础医学院 [3]华西医科大学口腔医学院

出　　处：《药学学报》1993年第8期604-608,共5页Acta Pharmaceutica Sinica

基　　金：卫生部青年科学研究基金

摘　　要：用乳化化学交联法制备出适合于颌面部鳞癌殒外动脉栓塞用顺铂白蛋白微球;外观呈黄色粉末状,收率80±5%,显微观察呈圆球体,平场粒径56.3μm:药物含量为14.02～14.2%,包封率97.08～97.95%。对其体外释药、灭菌、稳定性及分散溶媒的处方进行了探讨。通过动物实验表明该微球可以达到理想的栓塞效果,并保证能在局部组织停留,有利于提高抗癌药物的疗效,降低毒副作用。In this paper the technique of emulsion chemical-crosslinking was used to prepare cisplatin albumin microsphere for jaw squamous cancer by neck external artery embolization. It was yellow powder with yield 80±5%, mean size 56.3μm, cisplatin concentration 14.02～14.20%, loading rate 97.08～97.95%. The release characteristics in vitro, sterilization, stability and recipe of disperse solvent of cisplatin albumin microsphere were investigated. Animal test showed that cisplatin albumin microsphere may plug the branches of neck external artery well and remain in local tissue.

关 键 词：顺铂 颌面部鳞癌 清蛋白微球 

分 类 号：R979.1[医药卫生—药品]